Clicky

Wednesday, November 4, 2026

Companies

Public company updates

Alpha Modus Holdings Reports Significant Shareholding Change

Alpha Modus Holdings, Inc. reveals major shareholding changes in recent SEC filing, indicating shifts in ownership dynamics within the patent leasing industry.

Matson CEO Matthew J. Cox Reports Stock Sales in SEC Filing

Matthew J. Cox, CEO of Matson, Inc., sold shares on October 29, 2026, as reported in a recent SEC filing, raising questions about future company strategies.

Aspen Neuroscience reports key ownership changes in filing

Aspen Neuroscience's recent SEC filing highlights ownership changes that could impact its market position in the pharmaceutical sector.

Aspen Neuroscience sees key ownership changes in SEC filing

Aspen Neuroscience, Inc. reveals significant ownership changes in its latest SEC filing, indicating increased investor confidence in the pharmaceutical sector.

Aspen Neuroscience reports ownership changes in SEC filing

Aspen Neuroscience, Inc. discloses ownership changes by Executive Chair Hasnain Faheem, highlighting the company's developments in pharmaceutical preparations.

Aspen Neuroscience reports new ownership changes in SEC filing

Aspen Neuroscience reveals new ownership changes, enhancing director Daniel Thomas O's stake in the company, indicating growth in the pharmaceutical sector.

HealthStream Executive Trisha Coady Reports Stock Transactions

Trisha L. Coady of HealthStream Inc reports stock transactions in an SEC filing, reflecting ongoing confidence in the company's future.

Aspen Neuroscience reveals new ownership details in filing

Aspen Neuroscience, Inc. has disclosed new ownership details in its latest SEC filing, highlighting growth in the pharmaceutical preparations sector.

Collier Michael Manning Reports Stock Transactions on Oct. 29

Collier Michael Manning discloses stock and restricted share unit transactions, reflecting ongoing commitment to HealthStream Inc. and industry trends.

Frist Acquires Shares in HealthStream Amid Ongoing Growth

Robert A. Frist Jr. acquires shares in HealthStream, signaling confidence in the company's future and impacting the business services sector.

HealthStream CTO Jeff Cunningham Reports Stock Transactions

Jeff Cunningham, CTO of HealthStream Inc., reported stock transactions in an SEC filing, reflecting his ongoing commitment to the company's equity.

Aspen Neuroscience reports director change in SEC filing

Aspen Neuroscience, Inc. announces a new director, Douglas Carl Fisher, in a recent SEC filing, signaling potential shifts in company strategy.

Aspen Neuroscience reports ownership changes by director

Aspen Neuroscience, Inc. announces ownership changes by director Damien McDevitt, signaling potential shifts in management and strategy.

HealthStream's O'Hara Reports Stock Transactions in SEC Filing

Kevin O'Hara, EVP of HealthStream, disclosed stock transactions in an SEC filing, reflecting executive compensation changes in the tech services sector.

Kurtz George Sells Shares in CrowdStrike Holdings, Inc.

Kurtz George, CEO of CrowdStrike, reported multiple stock sales in SEC filing, reflecting ongoing management activity in the cybersecurity sector.

AXT Inc. CEO Young Receives Stock Grant Under Incentive Plan

AXT Inc. CEO Morris S. Young awarded 23,350 shares under the 2025 Equity Incentive Plan, emphasizing leadership incentives in the semiconductor sector.

AXT Inc. CFO Receives Restricted Stock Grant

AXT Inc. CFO Gary L. Fischer has been granted 8,524 shares of restricted stock as part of the company's incentive plan, reflecting a commitment to executive rewards.

HealthStream SVP McQuigg Reports Stock Transactions

Michael Scott McQuigg of HealthStream Inc. reports stock transactions, including acquisitions and disposals, reflecting ongoing compensation strategies.

HealthStream SVP Jennifer LoPresto Reports Stock Transactions

Jennifer LoPresto of HealthStream Inc. discloses stock transactions, reflecting executive engagement and confidence in the company's future.

Aspen Neuroscience CFO Meeter Dalen Files SEC Form 3

Aspen Neuroscience's CFO Meeter Dalen files SEC Form 3, detailing stock options and ownership changes, reflecting transparency in executive operations.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →